IL182517A - SYSTEM AND METHOD FOR PRODUCTION OF FUNCTIONAL HUMAN IgG4 ANTIBODIES IN PLANT CELL CULTURE - Google Patents

SYSTEM AND METHOD FOR PRODUCTION OF FUNCTIONAL HUMAN IgG4 ANTIBODIES IN PLANT CELL CULTURE

Info

Publication number
IL182517A
IL182517A IL182517A IL18251707A IL182517A IL 182517 A IL182517 A IL 182517A IL 182517 A IL182517 A IL 182517A IL 18251707 A IL18251707 A IL 18251707A IL 182517 A IL182517 A IL 182517A
Authority
IL
Israel
Prior art keywords
rhcrkd
barhcrkd
bat
pglkd210
protalix
Prior art date
Application number
IL182517A
Other languages
English (en)
Other versions
IL182517A0 (en
Inventor
Yoseph Shaaltiel
Gideon Baum
Sharon Hashmueli
Daniel Bartfeld
Tal Ratz
Einat Mizrachi
Yehava Forester
Original Assignee
Yoseph Shaaltiel
Protalix Ltd
Gideon Baum
Sharon Hashmueli
Daniel Bartfeld
Tal Ratz
Einat Mizrachi
Yehava Forester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoseph Shaaltiel, Protalix Ltd, Gideon Baum, Sharon Hashmueli, Daniel Bartfeld, Tal Ratz, Einat Mizrachi, Yehava Forester filed Critical Yoseph Shaaltiel
Publication of IL182517A0 publication Critical patent/IL182517A0/en
Publication of IL182517A publication Critical patent/IL182517A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/13Immunoglobulins specific features characterized by their source of isolation or production isolated from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL182517A 2004-10-13 2007-04-12 SYSTEM AND METHOD FOR PRODUCTION OF FUNCTIONAL HUMAN IgG4 ANTIBODIES IN PLANT CELL CULTURE IL182517A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61764604P 2004-10-13 2004-10-13
PCT/IL2005/001075 WO2006040764A2 (en) 2004-10-13 2005-10-11 System and method for production of antibodies in plant cell culture

Publications (2)

Publication Number Publication Date
IL182517A0 IL182517A0 (en) 2007-09-20
IL182517A true IL182517A (en) 2012-06-28

Family

ID=35462268

Family Applications (1)

Application Number Title Priority Date Filing Date
IL182517A IL182517A (en) 2004-10-13 2007-04-12 SYSTEM AND METHOD FOR PRODUCTION OF FUNCTIONAL HUMAN IgG4 ANTIBODIES IN PLANT CELL CULTURE

Country Status (12)

Country Link
US (1) US8119406B2 (de)
EP (1) EP1799813B1 (de)
JP (1) JP2008515454A (de)
KR (1) KR20070085291A (de)
AT (1) ATE468390T1 (de)
AU (1) AU2005293147A1 (de)
CA (1) CA2583691A1 (de)
DE (1) DE602005021379D1 (de)
IL (1) IL182517A (de)
MX (1) MX2007004414A (de)
WO (1) WO2006040764A2 (de)
ZA (1) ZA200703124B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032211A1 (en) * 1996-09-26 2005-02-10 Metabogal Ltd. Cell/tissue culturing device, system and method
IL155588A0 (en) * 2003-04-27 2003-11-23 Metabogal Ltd Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
US20100196345A1 (en) * 2003-04-27 2010-08-05 Protalix Production of high mannose proteins in plant culture
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
CA2583691A1 (en) 2004-10-13 2006-04-20 Protalix Ltd. System and method for production of antibodies in plant cell culture
JP2010517558A (ja) * 2007-02-09 2010-05-27 サントル ナショナル ドゥ ラ ルシェルシュ スィヤンティフィック(セーエヌエルエス) オストレオコッカス(Ostreococcus)種の核ゲノムからのポリペプチドの発現
BRPI0810343B1 (pt) 2007-05-07 2021-03-30 Protalix Ltd Dispositivo descartável para o cultivo e colheita de tecidos vegetais e/ou células, método de cultivo e colheita de um tecido vegetal e/ou células vegetais em um volume maior do que 400 litros e sistema de cultivo da célula vegetal
EP3009145A1 (de) 2009-03-30 2016-04-20 Mount Sinai School of Medicine of New York University Impfstoffe gegen das grippevirus und ihre verwendungen
EP2470199B1 (de) 2009-08-28 2019-05-22 Icahn School of Medicine at Mount Sinai Dosiserhöhungs- und enzymersatztherapie zur behandlung mangelnder saurer sphingomyelinase
EP3248615A1 (de) 2010-03-30 2017-11-29 Mount Sinai School of Medicine of New York University Influenzavirus-impfstoffe und verwendungen davon
IN2014CN02114A (de) 2011-09-20 2015-05-29 Sinai School Medicine
EP4154907A1 (de) 2012-12-18 2023-03-29 Icahn School of Medicine at Mount Sinai Influenzavirusimpfstoffe und verwendungen davon
US9908930B2 (en) 2013-03-14 2018-03-06 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
US10214747B2 (en) 2014-01-09 2019-02-26 Kentucky Bioprocessing, Inc. Method of purifying monoclonal antibodies
GB201411802D0 (en) 2014-07-02 2014-08-13 Univ Bradford Effervescent compositions
US9340604B1 (en) 2014-10-29 2016-05-17 Aridis Pharmaceuticals, Inc. Human monoclonal antibody specific for the F protein of respiratory syncytial virus (RSV)
WO2016118937A1 (en) 2015-01-23 2016-07-28 Icahn School Of Medicine At Mount Sinai Influenza virus vaccination regimens
CN109641041A (zh) 2016-06-15 2019-04-16 西奈山伊坎医学院 流感病毒血细胞凝集素蛋白及其用途
EP3550028A4 (de) 2016-11-30 2020-09-02 Kirin Holdings Kabushiki Kaisha Verfahren zur herstellung von nützlichen proteinen mithilfe einer pflanze
CA3058652A1 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080560A (en) * 1994-07-25 2000-06-27 Monsanto Company Method for producing antibodies in plant cells
AR020090A1 (es) 1998-06-15 2002-04-10 John Innes Ct Celula vegetal monocotiledonea o semilla de ella,planta o parte de una planta, metodo para hacer una celula vegetal monocotiledonea, metodo para hacer unaplanta, uso de una construccion de expresion para producir una celula de planta o semilla monocotiledonea, y uso de una construccion de expresion
WO2000011953A1 (en) * 1998-09-01 2000-03-09 Penn State Research Foundation Method and apparatus for aseptic growth or processing of biomass
US6528063B2 (en) * 1999-01-04 2003-03-04 Rahan Meristem Recombinant vaccines against IBDV
US6962700B1 (en) * 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
JP2004535192A (ja) * 2001-06-08 2004-11-25 イコン ジェネティクス インコーポレイティッド 植物中におけるタンパク質の産生
WO2003013598A2 (en) 2001-08-09 2003-02-20 Lam Dominic M K Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases
AR042145A1 (es) 2002-11-27 2005-06-08 Dow Agrociences Llc Produccion de inmunoglobulinas en plantas con una fucocilacion reducida
DK1431394T3 (da) 2002-12-20 2006-12-11 Greenovation Biotech Gmbh Fremgangsmåde til fremstilling af heterologe, glycosylerede proteiner i mosplanteceller
CA2583691A1 (en) 2004-10-13 2006-04-20 Protalix Ltd. System and method for production of antibodies in plant cell culture

Also Published As

Publication number Publication date
ZA200703124B (en) 2008-08-27
MX2007004414A (es) 2007-09-25
CA2583691A1 (en) 2006-04-20
IL182517A0 (en) 2007-09-20
JP2008515454A (ja) 2008-05-15
WO2006040764A3 (en) 2006-07-06
EP1799813A2 (de) 2007-06-27
AU2005293147A1 (en) 2006-04-20
ATE468390T1 (de) 2010-06-15
US8119406B2 (en) 2012-02-21
EP1799813B1 (de) 2010-05-19
US20090082548A1 (en) 2009-03-26
WO2006040764A2 (en) 2006-04-20
DE602005021379D1 (de) 2010-07-01
KR20070085291A (ko) 2007-08-27

Similar Documents

Publication Publication Date Title
IL182517A (en) SYSTEM AND METHOD FOR PRODUCTION OF FUNCTIONAL HUMAN IgG4 ANTIBODIES IN PLANT CELL CULTURE
Kirchhoff et al. Monoclonal tobacco cell lines with enhanced recombinant protein yields can be generated from heterogeneous cell suspension cultures by flow sorting
JPH03108478A (ja) 植物細胞ゲノムへの発現可能な遺伝子の導入法
US20100170006A1 (en) Methods for screening of novel functions of receptor like kinases
JP2008505626A5 (de)
CA2573022A1 (en) Novel sequence for improving expression of nucleic acid
CN116554305A (zh) 重组人源化iii型胶原蛋白、制备方法及其应用
CN104946687A (zh) 哺乳动物双基因高效筛选表达载体及其构建方法
CA2306229C (en) Positive-negative selection for homologous recombination
Arokiaraj et al. Expression of human serum albumin in transgenic Hevea brasiliensis
CN103038352A (zh) 用于增强基因表达的新型基因间元件
CN106191090B (zh) 无抗生素表达外源基因的蓝藻工程菌系统及其制备和应用
CN103060370A (zh) 可灵活置换调控元件的高效植物表达载体及其构建方法
WO2008091276A2 (en) Use of chick beta actin gene intron-1
CN109652435A (zh) 用于鼠伤寒沙门氏菌基因靶向点突变的重组质粒及相应的基因靶向点突变方法
AU600481B2 (en) Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same
CN103865947A (zh) 一种包含弱化的sv40启动子/二氢叶酸还原酶表达元件的真核表达载体及其构建方法
CN102776161A (zh) 分离自土壤的高抗草甘膦epsp合酶及其编码序列的制备和用途
CN102558316B (zh) 高稳定性的具抗体结合能力的重组蛋白a及其生产
JP2010514698A5 (de)
CN112375741A (zh) 一种高表达sars-cov2-rbd的细胞株及其方法
CN109402096B (zh) 一种aid酶突变体及其应用
CN101538579B (zh) 一种构建和生产限制性内切酶Ecop15I的方法
CN103374068A (zh) 一种新的单克隆抗体的制备方法及用途
CN116751792B (zh) 一种转录因子下游基因筛选方法

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed